IndiaCOVID-19Ministry of Health and Family WelfareHealth

COVID – 19 Vaccination Update – Day 392

India’s cumulative vaccination coverage crosses 172 Crore. More than 42 lakh Vaccine doses administered today till 7 pm

India’s COVID-19 vaccination coverage has crossed 172 Crore (1,72,24,21,476today. More than 42 lakh (42,67,532Vaccine Doses have been administered till 7 pm today. More than 1.68 Crore (1,68,47,437) Precaution Doses for the identified categories of beneficiaries (HCWs, FLWs and Over 60 years) for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10399084
2nd Dose 9925400
Precaution Dose 3840842
FLWs 1st Dose 18404496
2nd Dose 17364730
Precaution Dose 5239680
Age Group 15-18 years 1st Dose 51631391
  2nd Dose 13312332
Age Group 18-44 years 1st Dose 547434379
2nd Dose 424429543
Age Group 45-59 years 1st Dose 201491138
2nd Dose 175843233
Over 60 years 1st Dose 125787538
2nd Dose 109550775
Precaution Dose 7766915
Cumulative 1st dose administered 955148026
Cumulative 2nd dose administered 750426013
Precaution Dose 16847437
Total 1722421476

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 11th February, 2022 (392nd Day)
HCWs 1st Dose 132
2nd Dose 3959
Precaution Dose 30738
FLWs 1st Dose 322
2nd Dose 7526
Precaution Dose 87388
Age Group 15-18 years 1st Dose 296197
  2nd Dose 1215212
Age Group 18-44 years 1st Dose 366221
2nd Dose 1414031
Age Group 45-59 years 1st Dose 70868
2nd Dose 302485
Over 60 years 1st Dose 56892
2nd Dose 186727
Precaution Dose 228834
Cumulative 1st dose administered 790632
Cumulative 2nd dose administered 3129940
Precaution Dose 346960
Total 4267532

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker